Panchsheel organics Limited has announced a board meeting to review its quarterly financial performance and consider dividend distribution for shareholders. The pharmaceutical company, which manufactures bulk drugs and formulations, will convene its board of directors on February 14, 2026.

Board Meeting Agenda

The board meeting has been scheduled in compliance with Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The meeting will be held at the company's office located at 137, Hubtown Solaris, Prof. N S Phadke Marg, Opposite Teli Gali, Andheri (East), Mumbai – 400069, Maharashtra.

Key Agenda Items

The board will consider and approve several important matters during the meeting:

• Unaudited Standalone Financial Results: Review and approval of the company's financial performance for the quarter ended December 31, 2025
• Interim Dividend Declaration: Consideration and approval of interim dividend distribution to shareholders
• Other Matters: Any additional business items with the permission of the Chair

Trading Window Restrictions

The company has implemented trading window restrictions in accordance with regulatory requirements. The trading window for dealing in the company's securities by specified persons was closed with effect from Thursday, January 1, 2026. This restriction will remain in place until 48 hours after the financial results are made public on February 14, 2026.

Company Information

Panchsheel Organics Limited operates as a pharmaceutical manufacturer specializing in bulk drugs and formulations. The company is listed on BSE Limited with scrip code 531726. The board meeting announcement was signed by Mahendra Abhaychand Turakhia, Managing Director (DIN: 00006222), and communicated to BSE Limited on February 9, 2026.

The company maintains its corporate office at 1st floor, 137 Hubtown Solaris, N.S. Phadke Road, Opp. Teli Galli, Near Andheri East West Flyover Bridge, Andheri East, Mumbai - 400069, with CIN No. L24232MP1989PLC005390.

Panchsheel Organics Limited has announced an interim dividend of Rs. 0.80 per equity share. This dividend represents 8% of the company's paid-up share capital, as approved by the Board of Directors during their meeting on August 14, 2025.

Dividend Details

Key Points

The company has set August 22, 2025, as the record date to determine shareholder eligibility for the dividend payment. This date is crucial for investors, as it establishes who will receive the dividend based on their shareholding status on that day.

Mahendra A. Turakhia, Managing Director of Panchsheel Organics Limited, confirmed these details in a regulatory filing. The announcement aligns with the company's obligations under Regulations 30 and 42 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Investor Implications

Shareholders of Panchsheel Organics Limited who are on the company's records as of August 22, 2025, will be eligible to receive the interim dividend. This payout represents a return on investment for the company's stockholders.

Investors should note that the ex-dividend date, typically one day before the record date, would be the last day to purchase shares to qualify for this dividend payment.

The company has stated that the dividend will be paid within the statutory 30-day period following its declaration, ensuring timely distribution to eligible shareholders.

This interim dividend announcement may be seen as a positive signal by the market, potentially reflecting the company's financial health and commitment to shareholder returns.